Morbilliform drug eruptions caused by trimethoprim-sulfamethoxazole.
作者信息
Takenaka Daisuke, Nishizawa Toshinori
机构信息
Postgraduate Clinical Training Center, Fujita Health University, Toyoake, Aichi, Japan.
Department of General Internal Medicine, St Luke's International University, Chuo-ku, Japan
出版信息
BMJ Case Rep. 2020 Sep 23;13(9):e238255. doi: 10.1136/bcr-2020-238255.
Abstract
摘要
相似文献
1
Morbilliform drug eruptions caused by trimethoprim-sulfamethoxazole.
BMJ Case Rep. 2020 Sep 23;13(9):e238255. doi: 10.1136/bcr-2020-238255.
2
Generalized erythematous skin eruptions due to trimethoprim itself and co-trimoxazole.
J Dermatol. 1998 Apr;25(4):269-71. doi: 10.1111/j.1346-8138.1998.tb02395.x.
3
[Toxicodermia: Presentation of a case].
Semergen. 2019 Apr;45(3):e13-e14. doi: 10.1016/j.semerg.2019.01.008. Epub 2019 Mar 11.
4
Co-trimoxazole induced acute thrombocytopenic purpura.
Emerg Med J. 2003 May;20(3):E3. doi: 10.1136/emj.20.3.e3.
5
Trimethoprim-Sulfamethoxazole-Induced Exacerbation of Anxiety and Depression.
Prim Care Companion CNS Disord. 2018 Aug 9;20(4):17l02224. doi: 10.4088/PCC.17l02224.
6
A suspected case of trimethoprim-sulfamethoxazole-induced loss of fingernails and toenails.
Pediatr Infect Dis J. 1999 Jan;18(1):76-7. doi: 10.1097/00006454-199901000-00023.
7
Skin rash in a transplant patient receiving multiple drugs.
Cleve Clin J Med. 2003 Dec;70(12):1071-5. doi: 10.3949/ccjm.70.12.1071.
8
[Acute generalized exanthematous pustulosis associated with recurrent urinary tract infections].
Hautarzt. 2009 Mar;60(3):226-8. doi: 10.1007/s00105-008-1604-1.
9
Clinical pearls: Rash.
Acad Emerg Med. 1998 Oct;5(10):1018, 1029-31. doi: 10.1111/j.1553-2712.1998.tb02784.x.
10
Adverse reaction to sulphonamides in a burned patient--a case report.
Burns Incl Therm Inj. 1985 Dec;12(2):127-31. doi: 10.1016/0305-4179(85)90039-7.
本文引用的文献
1
Rubella Resurgence in Japan 2018-2019.
J Travel Med. 2019 Sep 2;26(6). doi: 10.1093/jtm/taz047.
2
Transmission potential of modified measles during an outbreak, Japan, March‒May 2018.
Euro Surveill. 2018 Jun;23(24). doi: 10.2807/1560-7917.ES.2018.23.24.1800239.
3
Assessment of histopathological features of maculopapular viral exanthem and drug-induced exanthem.
J Cutan Pathol. 2017 Dec;44(12):1038-1048. doi: 10.1111/cup.13047. Epub 2017 Oct 13.
4
Viral exanthems: An update on laboratory testing of the adult patient.
J Am Acad Dermatol. 2017 Mar;76(3):538-550. doi: 10.1016/j.jaad.2016.08.034. Epub 2016 Oct 26.
5
Clinical practice. Exanthematous drug eruptions.
N Engl J Med. 2012 Jun 28;366(26):2492-501. doi: 10.1056/NEJMcp1104080.
6
Considerations when prescribing trimethoprim-sulfamethoxazole.
CMAJ. 2011 Nov 8;183(16):1851-8. doi: 10.1503/cmaj.111152. Epub 2011 Oct 11.
7
Cutaneous drug eruptions: a 5-year experience.
J Am Acad Dermatol. 2008 Dec;59(6):995-9. doi: 10.1016/j.jaad.2008.09.015.
8
Atypical exanthems: morphology and laboratory investigations may lead to an aetiological diagnosis in about 70% of cases.
Br J Dermatol. 2002 Aug;147(2):255-60. doi: 10.1046/j.1365-2133.2002.04826.x.
Zotero 插件